Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure
- 9 December 2003
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Cell Metabolism
- Vol. 108 (23), 2941-2948
- https://doi.org/10.1161/01.cir.0000103683.99399.7e
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Thiazolidinedione-Associated Congestive Heart Failure and Pulmonary EdemaMayo Clinic Proceedings, 2003
- Metformin and Thiazolidinedione Use in Medicare Patients With Heart FailureJAMA, 2003
- Pioglitazone, a Peroxisome Proliferator–Activated Receptor-γ Agonist, Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial InfarctionCirculation, 2002
- Peripheral edemaAmerican Journal Of Medicine, 2002
- Management of Rosiglitazone-Induced Edema: Two Case Reports and a Review of the LiteratureDiabetes Technology & Therapeutics, 2002
- Metabolic and Additional Vascular Effects of ThiazolidinedionesDrugs, 2002
- ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summaryJournal of the American College of Cardiology, 2001
- Risk Factors for Congestive Heart Failure in US Men and WomenArchives of Internal Medicine, 2001
- Pulmonary Edema Associated With Troglitazone TherapyArchives of Internal Medicine, 1999
- Cardiac and Glycemic Benefits of Troglitazone Treatment in NIDDMDiabetes, 1997